Clinical trialRSS2 days ago
How an EBV Vaccine Could Be a Major MS Disrupter
Scientists are testing a new vaccine against Epstein-Barr virus (EBV), a common virus that may trigger multiple sclerosis (MS). Early research suggests that preventing EBV infection could help prevent or reduce MS development. This vaccine could be a major breakthrough for people at risk of developing MS or those already living with the disease.
WHY IT MATTERSIf successful, an EBV vaccine could prevent MS from developing in the first place, offering a potential cure-like approach rather than just managing symptoms after diagnosis.